Acurx Pharmaceuticals, Inc. (ACXP) vs Basel Medical Group Ltd Ordinary Shares (BMGL)
A side-by-side comparison of Acurx Pharmaceuticals, Inc. and Basel Medical Group Ltd Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACXP
Acurx Pharmaceuticals, Inc.
$1.31HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
BMGL
Basel Medical Group Ltd Ordinary Shares
$3.17HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACXP vs BMGL
growth of $100 · dividends reinvested · last 2yACXP -90.9% (-69.9%/yr)BMGL -94.1% (-75.6%/yr)ACXP compounded faster over this window
ACXP BMGL
ACXP vs BMGL: by the numbers
- •ACXP is the larger company ($6M vs $5M market cap).
- •Both run net losses; ACXP's is the smaller (0.00% vs -106.78% net margin).
Metrics side by side
Valuation
| Metric | ACXP | BMGL |
|---|---|---|
| P/B ratio | 0.69 | 1.02 |
Profitability
| Metric | ACXP | BMGL |
|---|---|---|
| Gross margin | 0.00% | 77.68% |
| Operating margin | 0.00% | -19.28% |
| Net margin | 0.00% | -106.78% |
| ROE | -92.08% | -248.66% |
| ROIC | -94.08% | -35.07% |
Growth (annualized)
| Metric | ACXP | BMGL |
|---|---|---|
| Total return CAGR (5Y) | -57.41% | N/A |
Go deeper
Dig into the metrics
Acurx Pharmaceuticals ROEBasel Medical Group Ltd Ordinary Shares ROEAcurx Pharmaceuticals operating marginBasel Medical Group Ltd Ordinary Shares operating marginAcurx Pharmaceuticals revenue growthBasel Medical Group Ltd Ordinary Shares revenue growthAcurx Pharmaceuticals free cash flowBasel Medical Group Ltd Ordinary Shares free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.